This activity already occurred and is no longer available.
Clinical Dialogue: Complexity in Care for Patients with Heart Failure: Highlighting the Role of the PA
This activity outlines management, recommendations and treatment for patients with heart failure. Also available, eCase Challenge and Monograph Complexity in Care for Patients with Heart Failure: Highlighting the Role of the PA.

Complexity in Care for Patients with Heart Failure: Highlighting the Role of the PA

Lawrence Herman, MPA, PA-C, DFAAPA; Daniel Thibodeau, MHP, PA-C, DFAAPA; Todd Nolen, MPA, PA-C

Heart Failure (HF) is a complex disease that affects millions of patients in the U.S. and represents a significant burden to the healthcare system. The effective management of such a multifaceted disease requires coordinated care, including that of PAs in a primary care setting. Thus, CME directives such as this should have the goal of highlighting the importance of PAs in the overall best care for patients. The presentation of HF patients with additional, and often multiple, comorbidities sometimes creates a muddled and unclear approach as how best to handle therapeutic strategies for the optimal clinical management of patients. As such, PAs should review the best practices outlined for HF care and treatment, and remain mindful that their treatment of other conditions does not compromise care for HF. Through active engagement with other members of the care team, PAs can effectively liaise and coordinate care for patients, a requirement given the complexity of the disease. Part of optimal management is also recognizing when the disease is progressing and methods to monitor progression. One way to monitor worsening symptoms is through patient self-assessment and self-care using non-pharmacological approaches. PAs can help to implement compliance with such approaches as physical activity, daily weight monitoring, sodium and fluid restriction and blood pressure monitoring by addressing the benefits of these activities with each visit. PAs can also encourage the use of a daily log to provide a record of any notable changes, which is a simple action to make at the clinician level. Importantly, in light of the recent approval of therapies after many years without change to the treatment landscape, PAs should familiarize themselves with these newer therapies and their potential advantages and limitations. 

Educational Objectives

At the conclusion of this activity, the PA should be better able to:

  • Discuss the implications of managing multiple comorbidities in patients with heart failure.
  • Recognize when patients’ heart failure symptoms are worsening.
  • Propose a plan for engaging with other members of the medical care team to proactively develop treatment plans and contingencies for their patients with HF.
  • Summarize the current non-pharmacological recommendations for patient self-care, including ways to monitor sodium and fluid intake, daily weight monitoring, blood pressure, and exercise.
  • Discuss the role of therapies currently available for HF, including those with recent approvals, and outline notable contraindications with other medications.

Accreditation Statement

This activity has been reviewed and is approved for a maximum of 0.50 AAPA Category 1 CME credit by the AAPA Review Panel. Participants should only claim credit commensurate with their participation in the CME activity. This program was planned in accordance with AAPA’s CME Standards for Enduring Material Programs and for Commercial Support of Enduring Material Programs. Approval is valid until January 31, 2018.

Responsibility Statement

AAPA takes responsibility for the content, quality, and scientific integrity of this CME activity.

Disclosure Policy Statement

It is the policy of AAPA to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member has with the commercial interest of any commercial product discussed in an educational presentation. The participating faculty reported the following:

Faculty

Lawrence Herman, MPA, PA-C, DFAAPA
Moderator
Dean and Professor
College of Health Sciences
PA Studies
Gardner-Webb University
Boiling Springs, NC
No relationship with any commercial interests whose products or services may be mentioned during this presentation.

Daniel Thibodeau, MHP, PA-C, DFAAPA
Associate Professor
Director Clinical Education Recruitment and Support
Eastern Virginia Medical School
Norfolk, VA
No relationship with any commercial interests whose products or services may be mentioned during this presentation.

Todd Nolen, MPA, PA-C
Cardiopulmonary Intensive Care
Dallas Veterans Affairs Medical Center
Dallas, TX
No relationship with any commercial interests whose products or services may be mentioned during this presentation.

Activity Planners

Michael Speidel and Joanne Jeffers, Medical Logix, LLC and Jennifer Gregg, PhD, have no relationship with any commercial interests whose products or services may be mentioned during this presentation.

AAPA Staff Activity Planners

Daniel Pace and Jennifer Williams have no relationship with any commercial interests whose products or services may be mentioned during this presentation.

Off-Label/Unapproved Product(s) Discussion

There are no references to off-label/unapproved uses of products in this program.

Disclaimer

The opinions and comments expressed by faculty and other experts, whose input is included in this program, are their own. This enduring material is produced for educational purposes only. Please review complete prescribing information of specific drugs mentioned in this program including indications, contraindications, warnings, and adverse effects and dosage before administering to patients.

Acknowledgement of Commercial Support

Supported by an independent educational grant from Novartis.

AAPA offers no returns or refunds for online CME activities purchased through the AAPA store. All sales are final.


Type:     Internet Activity (Enduring Material)
541 Registered Users